These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24161683)

  • 1. Drugs, genes and the blues: pharmacogenetics of the antidepressant response from mouse to man.
    O'Leary OF; O'Brien FE; O'Connor RM; Cryan JF
    Pharmacol Biochem Behav; 2014 Aug; 123():55-76. PubMed ID: 24161683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
    Narasimhan S; Lohoff FW
    Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faster, better, stronger: towards new antidepressant therapeutic strategies.
    O'Leary OF; Dinan TG; Cryan JF
    Eur J Pharmacol; 2015 Apr; 753():32-50. PubMed ID: 25092200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of antidepressant response.
    Keers R; Aitchison KJ
    Expert Rev Neurother; 2011 Jan; 11(1):101-25. PubMed ID: 21158559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression.
    Malki K; Lourdusamy A; Binder E; Payá-Cano J; Sluyter F; Craig I; Keers R; McGuffin P; Uher R; Schalkwyk LC
    Pharmacogenet Genomics; 2012 Nov; 22(11):765-76. PubMed ID: 23026812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics in depression and antidepressants.
    Bondy B
    Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic considerations for late life depression therapy.
    Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From monoamines to genomic targets: a paradigm shift for drug discovery in depression.
    Wong ML; Licinio J
    Nat Rev Drug Discov; 2004 Feb; 3(2):136-51. PubMed ID: 15040578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurobiology of depression and antidepressant action.
    Willner P; Scheel-Krüger J; Belzung C
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2331-71. PubMed ID: 23261405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.
    Lett TA; Walter H; Brandl EJ
    CNS Drugs; 2016 Dec; 30(12):1169-1189. PubMed ID: 27752945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression: biomarker of antidepressant therapy?
    Menke A
    Int Rev Psychiatry; 2013 Oct; 25(5):579-91. PubMed ID: 24151803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.
    Tsai SJ; Hong CJ; Liou YJ
    Pharmacogenomics; 2008 Sep; 9(9):1353-8. PubMed ID: 18781861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
    Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
    Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression.
    Hale MW; Raison CL; Lowry CA
    Pharmacol Ther; 2013 Jan; 137(1):108-18. PubMed ID: 23017938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does minocycline have antidepressant effect?
    Pae CU; Marks DM; Han C; Patkar AA
    Biomed Pharmacother; 2008 Jun; 62(5):308-11. PubMed ID: 18267354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions.
    Lerer B; Macciardi F
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):255-75. PubMed ID: 12366879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings.
    Schosser A; Serretti A; Souery D; Mendlewicz J; Zohar J; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2012 Jul; 22(7):453-68. PubMed ID: 22464339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.